The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
For those curious about science which supports this hypothesis: Arillotta, D., et al. (2024). Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. Brain Sciences. PMID: 38928604
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Meaning this isn’t just shrinking waistlines. It may be quieting the entire reward system across everything. Food. Pleasure. Attachment. All of it.
Before we denounce this as rubbish, we need to admit that this class of drugs DOES act in the reward/pleasure pathways that are involved in addictions, sexual desire, and possibly love.